发明名称 |
Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
摘要 |
A tissue factor protein mutant capable of neutralizing the ability of endogenous tissue factor to induce coagulation is provided. A representative tissue factor mutant designated K165A, K166A TF is useful in a method for inhibiting thrombin-induced platelet aggregation in a mammal, either separately or in combination with a thrombolytic agent, an anticoagulant, or a GPIIbIIIa inhibitor.
|
申请公布号 |
US5739101(A) |
申请公布日期 |
1998.04.14 |
申请号 |
US19950440814 |
申请日期 |
1995.05.15 |
申请人 |
GENENTECH, INC. |
发明人 |
ROY, SOUMITRA;VEHAR, GORDON A. |
分类号 |
A61K38/00;C07K14/475;C07K14/745;C12N15/12;(IPC1-7):C07K14/745;A61K38/17;A61K38/36 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|